• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: STRYKER ORTHOPAEDICS-MAHWAH X3 TRIATHLON CS INSERT #5 9MM; PROSTHESIS, KNEE, PATELLO/FEMOROTIBIAL, SEMI-CONSTRAINED, UNCEMENTED, POROUS, CO

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

STRYKER ORTHOPAEDICS-MAHWAH X3 TRIATHLON CS INSERT #5 9MM; PROSTHESIS, KNEE, PATELLO/FEMOROTIBIAL, SEMI-CONSTRAINED, UNCEMENTED, POROUS, CO Back to Search Results
Catalog Number 5531G509
Medical Device Problem Code Insufficient Device Problem Information (3190)
Health Effect - Clinical Codes Pain (1994); Loss of Range of Motion (2032); Scar Tissue (2060); Injury (2348)
Date of Event 10/28/2011
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
The following devices were also listed in this report: triathlon asymmetric x3 patella; cat# 5551-g-350; lot# 9246, triathlon prim cem fxd bplt #5; cat# 5520b500; lot# s3kfn, triathlon cr fem comp #5 l-cem; cat# 5510f501; lot# ssmdb.It cannot be determined which, if any of these devices may have caused or contributed to the patient's experience.Review of the device history records indicate devices were manufactured and accepted into final stock with no relevant reported discrepancies.There have been two other similar events for the lot referenced.It was noted that the device is not available for evaluation.Should additional information become available, it will be provided in a supplemental report upon completion of the investigation.Device not returned.
 
Event or Problem Description
Based on the medical review in pi, it was reported that at 2-months postop on (b)(6) 2011, the patient's knee condition remained poor with 8/10 vas pain and unchanged poor 20° rom.Under a diagnosis of arthrofibrosis, a manipulation of the knee under anaesthesia (mua) was performed on (b)(6) 2011.
 
Event or Problem Description
Based on the medical review in pi, it was reported that at 2-months postop on (b)(60 2011, the patient's knee condition remained poor with 8/10 vas pain and unchanged poor 20° rom.Under a diagnosis of arthrofibrosis, a manipulation of the knee under anaesthesia (mua) was performed on (b)(6) 2011.
 
Additional Manufacturer Narrative
An event regarding rom and arthrofibrosis involving a triathlon insert was reported.The event was confirmed based on the medical review.Method & results: product evaluation and results: material analysis, visual, functional and dimensional inspections could not be performed as the device was not returned (it remained implanted at the time of the event).Medical records received and evaluation: a review of the provided medical information by a clinical consultant indicated: arthrofibrosis contributed to a severe degree of scar tissue formation post triathlon cr primary knee arthroplasty in (b)(6) 2011 requiring repeated interventions for treatment including manipulation under anaesthesia in (b)(6) 2018, a first knee revision with scar tissue removal plus femoral shortening with exchange of all components for new triathlon ts components in (b)(6) 2012, an arthroscopic removal of hematoma a few weeks later plus another knee revision with removal of exceptionally dense scar tissue plus quadriceps tendon lengthening in (b)(6) 2013 while retaining all devices.Residual pain was still present in 2018 although knee functionality appears to have been improved after the second revision.Arthrofibrosis is a procedure-related complication of potentially any knee arthroplasty with sometimes additional patient-related risk factors.A knee twisting trauma with collateral ligament injury in 1974 counts as risk factor for arthrofibrosis.No device-related factors are associated with any of the implanted devices at any time.Product history review: a review of the device manufacturing records indicate that all devices accepted into final stock were free from discrepancies.Complaint history review: there has been 1 other similar event for the lot referenced relating to the same patient and device.Conclusions: based on the medical review, arthrofibrosis contributed to a severe degree of scar tissue formation post triathlon cr primary knee arthroplasty in aug 2011 requiring repeated interventions for treatment.Arthrofibrosis is a procedure-related complication of potentially any knee arthroplasty with sometimes additional patient-related risk factors.A knee twisting trauma with collateral ligament injury in 1974 counts as risk factor for arthrofibrosis.No device-related factors are associated with any of the implanted devices at any time.No further investigation for this event is required at this time.If devices and / or additional information become available to indicate further evaluation is warranted, this record will be reopened.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
X3 TRIATHLON CS INSERT #5 9MM
Common Device Name
PROSTHESIS, KNEE, PATELLO/FEMOROTIBIAL, SEMI-CONSTRAINED, UNCEMENTED, POROUS, CO
Manufacturer (Section D)
STRYKER ORTHOPAEDICS-MAHWAH
325 corporate drive
mahwah NJ 07430
MDR Report Key9377330
Report Number0002249697-2019-03864
Device Sequence Number3040316
Product Code MBH
UDI-Device Identifier07613327045871
UDI-Public07613327045871
Combination Product (Y/N)N
Initial Reporter CountryUS
PMA/510(K) Number
K141056
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2011
Reporter Type Manufacturer
Report Source consumer,other
Initial Reporter Occupation Other
Type of Report Initial,Followup
Report Date (Section B) 01/07/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Expiration Date03/31/2016
Device Catalogue Number5531G509
Device Lot NumberLCI411
Was Device Available for Evaluation? No
Initial Date Received by Manufacturer 10/29/2019
Supplement Date Received by Manufacturer12/10/2019
Initial Report FDA Received Date11/26/2019
Supplement Report FDA Received Date01/07/2020
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Outcome Attributed to Adverse Event Other;
Patient Age59 YR
-
-